Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Sirona Biochem Brings In Former Bayer Executive Following AbbVie Deal

By: PRLog

Sirona Biochem Corp. (TSX-V: SBM) is tapping into the 30 years of experience of former Bayer executive Dr. Wolfgang Bieber to help bring the company to the next level. The appointment comes just days after Sirona Biochem signed an exclusive global licensing agreement with Allergan Aesthetics, an AbbVie company.

VANCOUVER, British Columbia - June 20, 2022 - PRLog -- Sirona Biochem announced Monday that it would be bringing Dr. Bieber into its Advisory Board. He will also be acting as a direct consultant to the company's Board of Directors. Part of his job will be to form new partnerships with chemical manufacturers in Europe. He will also help restructure the company to ensure sustainable growth.

Sirona Biochem CEO Dr. Howard Verrico said the company would stand to benefit from Dr. Bieber's years of experience and his extensive network within the biotech industry. He added that Dr. Bieber's guidance would be crucial as Sirona Biochem enters a new phase following its deal with AbbVie's Allergan Aesthetics.

In the company's press release, Dr. Bieber commented that he was looking forward to working with Sirona Biochem. He added that he was eager to contribute his experience and network to further accelerate its growth. Dr. Bieber acknowledged that Sirona Biochem's unique approach to chemistry presents incredible potential.

Dr. Bieber worked for Bayer as the Senior Vice-President in charge of operations of its biological production in the U.S. and its global agrochemical production. He is a key figure responsible for the success of products such as Kogenate®, one of the world's largest recombinant protein products. He was pivotal in helping the product reach annual sales of more than $1 billion.

He directly managed more than 1,250 employees, with direct expenses of over $300 million and capital expenses of more than $200 million throughout his career. During his tenure, Dr. Bieber was strongly involved in M&A activities, including major mergers such as with Aventis CropScience in 2001.

Following the completion of its exclusive licensing deal with AbbVie for its library of industry-disrupting skincare compounds, including the breakthrough TFC-1067, Sirona Biochem is presently adopting several initiatives to boost growth and pipeline development.

Sirona Biochem's novel carbohydrate compounds are licensed to leading biotech companies worldwide in return for licensing fees, milestone fees, and ongoing royalty payments. Its development focus is on high-valued programs selected for their core expertise in the area, market potential, development timeline, and return on investment.

To learn more, visit their website: https://www.sironabiochem.com/

Or download their Investor's Presentation – Sirona Biochem Investor's Presentation

Contact
All Web Consultancy
***@gmail.com

Photos: (Click photo to enlarge)

All Web Consultancy Logo Close Up Scientist Using Microscope Laboratory Roo

Read Full Story - Sirona Biochem Brings In Former Bayer Executive Following AbbVie Deal | More news from this source

Press release distribution by PRLog
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.